Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma
Vinod Kumar(University Medical Center Groningen), Koichi Matsuda(The University of Tokyo), Ryosuke Tateishi(Bunkyo University), Masao Omata(University of Yamanashi Hospital), Ryosuke Muroyama(The University of Tokyo), Katsushi Tokunaga(National Center for Global Health and Medicine), Naoya Kato(The University of Tokyo), Kazuhiko Koike(Kanto Central Hospital), Masaya Sugiyama(National Center for Global Health and Medicine), Paulisally Hau Yi Lo(The University of Tokyo), Hamdi Mbarek(King's College London), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Chizu Tanikawa(The University of Tokyo), Zhenzhong Deng(The University of Tokyo), Atsushi Takahashi(Fukushima Medical University), Naoyuki Kamatani, Yusuke Nakamura(Rissho University), Hiromi Sawai(The University of Tokyo), Yuji Urabe(The University of Tokyo), Masashi Mizokami(National Institute of Advanced Industrial Science and Technology), Yasuhito Tanaka(Kumamoto University)
Cited by 94
Related Papers
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
|Hepatology International|2017|2.2k